At 6GSymposium, InterDigital to Lead Crucial Discussions on Emerging Use Cases and Avenues Towards 6G Profitability
September 09, 2024 04:00 ET
|
InterDigital, Inc.
InterDigital to lead crucial discussion on 6G development at D.C. 6GSymposium
Immunovant Provides Update on Graves’ Disease Development Program
September 09, 2024 03:55 ET
|
Immunovant Inc.
High dose batoclimab achieved 76% response rate in patients uncontrolled on antithyroid drugs (ATDs) at week 12High dose batoclimab achieved 56% ATD-Free response rate in patients uncontrolled on ATDs...
LifeWallet Launches Initiative to Secure New Agreements with Health Plans, Providers, Insurers and Attorneys, Continues Cost Cutting Efforts, and Announces it Secured a Waiver of Acceleration Based on a Negative Going Concern from its Largest Creditor
September 08, 2024 23:53 ET
|
LifeWallet
CORAL GABLES, Fla., Sept. 08, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) ("LifeWallet," or the "Company"), a Medicare, Medicaid, commercial, and Secondary Payer...
Methanex Corporation Signs Definitive Agreement to Acquire OCI Global’s International Methanol Business for $2.05 Billion
September 08, 2024 21:00 ET
|
Methanex Corporation
Except where otherwise noted, all currency amounts are stated in United States dollars. Unique opportunity to acquire world-scale producing methanol assets with access to robust North American...
HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer
September 08, 2024 20:00 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from...
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
September 08, 2024 19:10 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Sept. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative...
NOVONIX Announces Participation in the H.C. Wainwright Conference
September 08, 2024 18:55 ET
|
Novonix Ltd.
BRISBANE, Australia, Sept. 09, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today announced that the company is...
C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
September 08, 2024 18:05 ET
|
C4 Therapeutics, Inc.
Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity Investor Webcast to be Held Friday, September 13, 2024 at 12:00 pm ET ...
Embrace Change Acquisition Corp. Receives Additional Staff Determination Notice from Nasdaq Related to Delayed Quarterly Report
September 07, 2024 23:00 ET
|
Embrace Change Acquisition Corp.
SAN DIEGO, Sept. 07, 2024 (GLOBE NEWSWIRE) -- Embrace Change Acquisition Corp. (Nasdaq: EMCG, EMCGW, EMCGU, EMCGR) ("Embrace Change" or the "Company"), announced today that on September 5, 2024, it...
2024年8月のハット8 (Hut 8) 運営アップデート
September 07, 2024 04:51 ET
|
Hut 8 Corp.
18.5 EH/sおよび762 MWが管理下に シダーベールのビル1 (Building 1) が通電 マイアミ発, Sept. 07, 2024 (GLOBE NEWSWIRE) -- 大規模エネルギーインフラストラクチャの大手垂直統合オペレーターであり、北米最大のビットコインマイナーの1つであるハット8コーポレーション (Hut 8 Corp.) (NASDAQ | TSX: HUT)...